2023-05-03 09:56:57 ET
- CNS Pharmaceuticals ( NASDAQ: CNSP ) has retained Shareholder Intelligence Services to investigate trading patterns of its stock amidst potential naked short selling .
- "We have zero tolerance for illegal naked short selling and any other manipulation of our stock," CEO John Climaco said in a statement . "We now have in place the tools to analyze the situation thoroughly and will not hesitate to act in the best interest of our shareholders should we uncover any illegal or otherwise prohibited trading activity."
- Although the stock is down ~43% year to date (based on Tuesday's close), on April 14, CNS Pharma ( CNSP ) closed at $2.35, a 243% gain from the day before. The following day, it closed at $2.75.
- As of 955a ET Wednesday morning, shares are up 25% to $1.90.
For further details see:
CNS Pharma investigation possible naked short selling